Pharmacokinetics and Biopharmaceutics of Biologics

APV-Course no. 6379, 20 and 21 June 2011, Berlin

Mainz, (PresseBox) - This course is designed to cover basic aspects of the non-clinical PK-development of biologics. Biologics have some special features influencing their metabolic pathways, distribution behaviour and PK/PD relationship. In contrast to small molecules biologics are usually inherently immunogenic with possible consequences on their PK/PD-behaviour and safety profile, requesting as well a broader bioanalytical methodology.

This course will present and explain several of these features by established scientists and developers in this field employing state of the art case studies on a basic, yet sufficiently detailed level to allow acquisition of the knowledge necessary to translate the principles into the daily work. Emphasis will be given to a conceptual understanding of the theory and practical use of pharmacokinetic and biopharmaceutic criteria for biologics within the overall non-clinical strategy and regulatory environment. The course will encourage the design of pharmacokinetic development programmes and enable the choice to be made of development compounds with appropriate pharmacokinetic properties. After attending this course, participants will be able to apply these principles in an up-to-date and practical way in an industrial, academic or regulatory setting. Attendees will also be better equipped to communicate successfully in meet ings involving project scientists, regulators and pharmacokineticists.

In addition to lectures, time allows for both formal and informal discussions and for networking with peers.

For more detailed information on the current programme please use the following link:

http://www.apv-mainz.de/fileadmin/Pdf_Programme_Jan_2011/6379.pdf

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.